Ridgetech, Inc. (NASDAQ: RDGT) Stock Competitors & Peer Comparison
See RDGT's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for RDGT and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RDGT | $0.83 | -1.59% | 745.1K | -0.02 | -$54.23 | N/A |
| MCK | $881.51 | +0.07% | 103.2B | 21.59 | $40.82 | +0.39% |
| COR | $321.57 | +0.19% | 62.6B | 18.75 | $17.15 | +0.75% |
| CAH | $234.57 | -0.61% | 54.9B | 22.49 | $10.43 | +0.87% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $88.36 | +1.21% | 10.1B | 16.64 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| AHG | $0.84 | +14.93% | 678.6M | -3.72 | -$0.21 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| EMPG | $17.36 | +0.00% | 143M | 192.89 | $0.09 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
RDGT vs MCK Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, MCK has a market cap of 103.2B. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while MCK trades at $881.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas MCK's P/E ratio is 21.59. In terms of profitability, RDGT's ROE is -0.04%, compared to MCK's ROE of -1.94%. Regarding short-term risk, RDGT is more volatile compared to MCK. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
RDGT vs COR Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, COR has a market cap of 62.6B. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while COR trades at $321.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas COR's P/E ratio is 18.75. In terms of profitability, RDGT's ROE is -0.04%, compared to COR's ROE of +1.06%. Regarding short-term risk, RDGT is more volatile compared to COR. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
RDGT vs CAH Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, CAH has a market cap of 54.9B. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while CAH trades at $234.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas CAH's P/E ratio is 22.49. In terms of profitability, RDGT's ROE is -0.04%, compared to CAH's ROE of -0.60%. Regarding short-term risk, RDGT is more volatile compared to CAH. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
RDGT vs ABC Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas ABC's P/E ratio is 21.92. In terms of profitability, RDGT's ROE is -0.04%, compared to ABC's ROE of +1.06%. Regarding short-term risk, RDGT is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
RDGT vs HSIC Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, HSIC has a market cap of 10.1B. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while HSIC trades at $88.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas HSIC's P/E ratio is 16.64. In terms of profitability, RDGT's ROE is -0.04%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, RDGT is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
RDGT vs PDCO Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas PDCO's P/E ratio is 20.48. In terms of profitability, RDGT's ROE is -0.04%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, RDGT is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check PDCO's competition here
Akso Health Group (NASDAQ: AHG)
RDGT vs AHG Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, AHG has a market cap of 678.6M. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while AHG trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas AHG's P/E ratio is -3.72. In terms of profitability, RDGT's ROE is -0.04%, compared to AHG's ROE of -0.50%. Regarding short-term risk, RDGT is less volatile compared to AHG. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check AHG's competition here
Owens & Minor, Inc. (NYSE: OMI)
RDGT vs OMI Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas OMI's P/E ratio is -0.47. In terms of profitability, RDGT's ROE is -0.04%, compared to OMI's ROE of +0.63%. Regarding short-term risk, RDGT is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check OMI's competition here
Empro Group Inc. Ordinary shares (NASDAQ: EMPG)
RDGT vs EMPG Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, EMPG has a market cap of 143M. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while EMPG trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas EMPG's P/E ratio is 192.89. In terms of profitability, RDGT's ROE is -0.04%, compared to EMPG's ROE of +0.66%. Regarding short-term risk, RDGT is more volatile compared to EMPG. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check EMPG's competition here
Accendra Health, Inc. (NYSE: ACH)
RDGT vs ACH Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, ACH has a market cap of 82.7M. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while ACH trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas ACH's P/E ratio is 1.59. In terms of profitability, RDGT's ROE is -0.04%, compared to ACH's ROE of +0.63%. Regarding short-term risk, RDGT is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check ACH's competition here
Akso Health Group (NASDAQ: HX)
RDGT vs HX Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas HX's P/E ratio is -1.84. In terms of profitability, RDGT's ROE is -0.04%, compared to HX's ROE of -1.07%. Regarding short-term risk, RDGT is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check HX's competition here
111, Inc. (NASDAQ: YI)
RDGT vs YI Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, YI has a market cap of 31.1M. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while YI trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas YI's P/E ratio is -2.54. In terms of profitability, RDGT's ROE is -0.04%, compared to YI's ROE of +0.14%. Regarding short-term risk, RDGT is less volatile compared to YI. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
RDGT vs WGRX Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas WGRX's P/E ratio is -0.33. In terms of profitability, RDGT's ROE is -0.04%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, RDGT is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check WGRX's competition here
Zynex, Inc. (NASDAQ: ZYXI)
RDGT vs ZYXI Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, RDGT's ROE is -0.04%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, RDGT is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check ZYXI's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
RDGT vs MEDS Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, MEDS has a market cap of 2.4M. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while MEDS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas MEDS's P/E ratio is N/A. In terms of profitability, RDGT's ROE is -0.04%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, RDGT is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check MEDS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
RDGT vs HKPD Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, HKPD has a market cap of 1.3M. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while HKPD trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas HKPD's P/E ratio is -2.04. In terms of profitability, RDGT's ROE is -0.04%, compared to HKPD's ROE of -0.15%. Regarding short-term risk, RDGT is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check HKPD's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
RDGT vs SNYR Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, SNYR has a market cap of 1.1M. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while SNYR trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas SNYR's P/E ratio is -0.07. In terms of profitability, RDGT's ROE is -0.04%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, RDGT is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check SNYR's competition here
Covetrus, Inc. (NASDAQ: CVET)
RDGT vs CVET Comparison September 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 745.1K. In comparison, CVET has a market cap of 0. Regarding current trading prices, RDGT is priced at $0.83 on the NASDAQ, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.02, whereas CVET's P/E ratio is -69.97. In terms of profitability, RDGT's ROE is -0.04%, compared to CVET's ROE of -0.06%. Regarding short-term risk, RDGT is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check CVET's competition here